TFF Pharmaceuticals TFFP

$ 0.07 -60.05%

Quarterly report 2024-Q3
added 11-20-2024

TFF Pharmaceuticals Income Statement 2011-2024 | TFFP

Annual Income Statement TFF Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	10.8 M	815 K	220 M	318 M	36 M	-	-	-	-	-	-	-	-
Shares	1.79 M	1.2 M	24.8 M	20.4 M	6.9 M	-	-	-	-	-	-	-	-
Historical Prices	6.05	0.68	8.87	14.3	5.35	-	-	-	-	-	-	-	-
Net Income	-21.2 M	-31.8 M	-31 M	-18.6 M	-11.9 M	-	-179 K	-	-	-	-	-	-
Revenue	734 K	496 K	88.2 K	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-21.9 M	-31.8 M	-31.8 M	-18.7 M	-12 M	-3.9 M	-	-	-	-	-	-	-
Interest Expense	14.5 K	26.7 K	51.2 K	126 K	117 K	56 K	-	-	-	-	-	-	-
EBITDA	-21.4 M	-31.4 M	-31.7 M	-18.7 M	-12 M	-	-179 K	-	-	-	-	-	-
Operating Expenses	22.6 M	32.3 M	31.9 M	18.7 M	12 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	10.6 M	13.8 M	293 K	8.01 M	3.17 M	-	179 K	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement TFF Pharmaceuticals

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	4.37 M	3.67 M	2.39 M	2.37 M	1.9 M	1.45 M	1.45 M	36.2 M	25.5 M	25.4 M	25.4 M	25.4 M	25.4 M	25.4 M	23.1 M	22.5 M	400 K	19.1 M	400 K	18.5 M	400 K	400 K	400 K	4 M	4.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-3.54 M	-4.48 M	-5.74 M	-	-4.41 M	-5.02 M	-7.05 M	-	-7.27 M	-8.75 M	-8.38 M	-	-8.68 M	-4.66 M	-7.65 M	-	-5.06 M	-3.82 M	-3.8 M	-	-2.84 M	-2.19 M	-2.18 M	-	-585 K	-2.12 M	-268 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	193 K	650 K	203 K	-	235 K	333 K	51.4 K	-	87.6 K	28 K	67.4 K	-	50 K	1.85 K	24.3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-3.58 M	-3.96 M	-5.79 M	-	-4.42 M	-5.02 M	-7.09 M	-	-7.28 M	-8.75 M	-8.38 M	-	-8.68 M	-5.11 M	-7.9 M	-	-5.08 M	-3.84 M	-3.85 M	-	-2.86 M	-2.21 M	-2.2 M	-	-606 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	15.6 K	-	-	36.1 K	35.1 K	-	6.12 K	5.88 K	7.18 K	-	12.1 K	14.1 K	15.5 K	-	20.5 K	26 K	56.3 K	-	25.9 K	22.2 K	19.6 K	-	20.9 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-5.65 M	-	-	-	-6.96 M	-	-7.01 M	-8.59 M	-8.31 M	-	-8.64 M	-5.11 M	-7.9 M	-	-5.08 M	-3.84 M	-3.85 M	-	-2.86 M	-2.21 M	-2.2 M	-	-606 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	3.78 M	4.61 M	5.99 M	-	4.66 M	5.35 M	7.14 M	-	7.37 M	8.78 M	8.45 M	-	8.73 M	5.11 M	7.93 M	-	5.08 M	3.84 M	3.85 M	-	2.86 M	2.21 M	2.2 M	-	606 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	2.08 M	2.02 M	2.44 M	-	2.27 M	2.67 M	3.12 M	-	3.34 M	3.68 M	3.21 M	-	2.39 M	2.35 M	2.65 M	-	2.25 M	1.27 M	1.62 M	-	301 K	889 K	532 K	-	466 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency